Table 2.
Study | Item | Total | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | ||
Bade M et al. 2016 [18] | Yes | Yes | No | Yes | No | No | No | Yes | Yes | Yes | Yes | 7 |
Cai C et al. 2017 [19] | Yes | Yes | Yes | Yes | No | No | No | Yes | No | Yes | Yes | 7 |
Fukuda TY et al. 2021 [20] | Yes | Yes | Yes | Yes | No | No | No | Yes | Yes | Yes | Yes | 8 |
Jeong UC et al. 2015 [21] | No | Yes | No | Yes | No | No | No | Yes | Yes | Yes | Yes | 6 |
Kendall KD et al. 2014 [22] | Yes | Yes | Yes | Yes | No | No | No | Yes | Yes | Yes | Yes | 8 |
Kim B and Yim 2020 [23] | Yes | Yes | Yes | Yes | Yes | No | Yes | Yes | No | Yes | Yes | 9 |
Lee SW et al. 2014 [24] | Yes | Yes | No | Yes | No | No | No | Yes | No | Yes | Yes | 6 |
PEDro questionnaire items → 1: eligibility criteria; 2: random assignment; 3: hidden allocation; 4: baseline comparison; 5: blind subjects; 6: blind therapist; 7: blind evaluators; 8: adequate follow-up; 9: intention-to-treat analysis; 10: comparison between groups; 11: point estimates and variability.